Effect of vitamin D supplementation on IL-37 and TNF-a in children with autism spectrum disorders

Not Applicable

Recruiting

• Conditions: Autism spectrum Disorders.; Autistic disorder; F84.0

• Registration Number: IRCT20170827035936N3
• Lead Sponsor: Kermanshah University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 16 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

The desire for parental collaboration The age range of 5 to 12 years
The diagnosis of autism disorder based on DSM-5 criteria

Exclusion Criteria

Reluctance to continue cooperation
Children with significant hearing loss and vision loss Other neurological disorders such as cerebral palsy, phenylketonuria, seizure disorders
History of head trauma, genetic abnormalities, premature children
children with nutritional and malnutrition problems, children with digestive problems
children with immune disorders, children with endocrine diseases, cardiovascular, pulmonary, kidney, liver
Children two months prior to study Supplements or the following medications, vitamin D, fish liver oil, steroids
Children with serum vitamin D levels above 80 ng / ml

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Serum level of 25 (OH)D3. Timepoint: at the beginning and the end of 12th week. Method of measurement: Elyssa.;Serum level of IL-37. Timepoint: at the beginning and the end of 12th week. Method of measurement: Elyssa.;Serum level of TN F-a. Timepoint: at the beginning and the end of 12th week. Method of measurement: Elyssa.